Author: Vijayan, Veena; Mohapatra, Adityanarayan; Uthaman, Saji; Park, In-Kyu
Title: Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials Document date: 2019_10_14
ID: 1d3xthbh_40
Snippet: Biomimetic nanovaccines are developed by the simulation of the synthetic NPs with biologically derived materials, and the combination of both the synthetic and biological properties is the key factor to improve the therapeutic efficacy of the treatment. Biomimetic nanovaccines come in several varieties, such as liposomes, proteins, cell-membrane-coated NPs, and VLPs modified with antigens and adjuvants (shown in Figure 4 ) for the stimulation of .....
Document: Biomimetic nanovaccines are developed by the simulation of the synthetic NPs with biologically derived materials, and the combination of both the synthetic and biological properties is the key factor to improve the therapeutic efficacy of the treatment. Biomimetic nanovaccines come in several varieties, such as liposomes, proteins, cell-membrane-coated NPs, and VLPs modified with antigens and adjuvants (shown in Figure 4 ) for the stimulation of immune responses in our body. Due to the presence of various cell membrane proteins and antibodies on the surface of nanovaccines, it is possible to quickly evade the immune system. Biomimetic surface engineering is an unusual approach towards developing current therapeutic actions. factor to improve the therapeutic efficacy of the treatment. Biomimetic nanovaccines come in several varieties, such as liposomes, proteins, cell-membrane-coated NPs, and VLPs modified with antigens and adjuvants (shown in Figure 4 ) for the stimulation of immune responses in our body. Due to the presence of various cell membrane proteins and antibodies on the surface of nanovaccines, it is possible to quickly evade the immune system. Biomimetic surface engineering is an unusual approach towards developing current therapeutic actions.
Search related documents:
Co phrase search for related documents- adjuvant antigen and immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- adjuvant antigen and immune system evade: 1
- adjuvant antigen and nanovaccine surface: 1, 2
- biomimetic nanovaccine and immune response: 1, 2, 3, 4, 5, 6, 7
- biomimetic nanovaccine and immune system: 1, 2
- biomimetic nanovaccine and immune system evade: 1
- biomimetic nanovaccine and nanovaccine surface: 1, 2, 3, 4, 5
- body immune response and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- body immune response and immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- body immune response and immune system evade: 1
- body immune response stimulation and immune response: 1
- body immune response stimulation and immune system: 1
- cell membrane and immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cell membrane and immune system evade: 1, 2, 3
- cell membrane and key factor: 1, 2, 3, 4, 5
- cell membrane and membrane coat: 1, 2
- cell membrane and nanovaccine surface: 1, 2, 3, 4
- cell membrane and quickly immune system evade: 1
- cell membrane and surface engineering: 1, 2
Co phrase search for related documents, hyperlinks ordered by date